(VIANEWS) – Shares of BENEVOLENTAI (AEX-Index: BAI.AS) dropped by a staggering 20.11% in 10 sessions from €3.48 to €2.78 at 13:09 EST on Thursday, after two successive sessions in a row of losses. AEX-Index is jumping 0.12% to €757.57, after four consecutive sessions in a row of losses.
BENEVOLENTAI’s last close was €3.00, 70% below its 52-week high of €10.00.
About BENEVOLENTAI
BenevolentAI société anonyme operates as a clinical-stage AI-enabled drug discovery company. The company's BenevolentAI platform powers a pipeline of approximately 20 drug programs. BenevolentAI société anonyme was formerly known as BenevolentAI Limited and changed its name to BenevolentAI société anonyme on April 22, 2022. The company is headquartered in London, United Kingdom.
More news about BENEVOLENTAI (BAI.AS).
